● Recruiting

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

Condition: Adenocarcinoma of Lung · Lung Cancer · Sponsor: Masonic Cancer Center, University of Minnesota

PhasePhase 2

Planned participants82

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a randomized, active-controlled, parallel-group, double-blind Phase II trial, of oral restorative microbiota therapy (RMT) or placebo combined with intravenous (IV) durvalumab (MEDI4736) plus chemotherapy in patients with treatment naïve advanced or metastatic adenocarcinoma non-small cell lung cancer (NSCLC)

This description comes directly from the study's public registry record.

Talk to the study team

Cancer Center Clinical Trials Office · 612 624 2620 · ccinfo@umn.edu

Always discuss trial participation with your own doctor first.

Locations (10)

Dr. Amit Kulkarni	Phoenix, Arizona, United States	Not Yet Recruiting
MNCCTN Essentia Health St. Joseph's Brainerd Medical Center	Brainerd, Minnesota, United States	Recruiting
MNCCTN Essentia Health Deer River	Deer River, Minnesota, United States	Recruiting
MNCCTN Essentia Health St. Mary's Detroit Lakes Clinic	Detroit Lakes, Minnesota, United States	Recruiting
MNCCTN Essentia Health Duluth	Duluth, Minnesota, United States	Recruiting
MNCCTN Essentia Health Fosston	Fosston, Minnesota, United States	Recruiting
MNCCTN Essentia Health Hibbing Clinic	Hibbing, Minnesota, United States	Recruiting
Masonic Cancer Center, University of Minnesota	Minneapolis, Minnesota, United States	Recruiting
MNCCTN Essentia Health Sandstone	Sandstone, Minnesota, United States	Recruiting
MNCCTN Essentia Health Virginia Clinic	Virginia, Minnesota, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04105270